Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Home
Authors
Posts by Tess Egginton
Tess Egginton
324 POSTS
0 COMMENTS
http://www.pbiforum.net
Featured
Construction complete on new multi-million gene therapy innovation centre
Tess Egginton
-
29th July 2022
0
APPROVALS
European Commission approves RINVOQ (upadacitinib) for the treatment of adults with moderate to severe ulcerative colitis
Tess Egginton
-
27th July 2022
0
Featured
NewAmsterdam Pharma and Frazier Lifesciences enter merger deal
Tess Egginton
-
27th July 2022
0
APPROVALS
MHRA grants marketing authorization for GBT’s Oxbryta for treatment of hemolytic anemia in patients with sickle cell disease 12 years and older
Tess Egginton
-
27th July 2022
0
Featured
European Orphan Medicinal Product Designation granted to Sangamo Therapeutics’ investigational CAR-Treg cell therapy TX200 for solid organ transplantation
Tess Egginton
-
25th July 2022
0
Featured
Silverback Therapeutics and ARS Pharmaceuticals to merge
Tess Egginton
-
25th July 2022
0
Featured
Karyopharm granted new regulatory designations for eltanexor for the treatment of myelodysplastic syndromes
Tess Egginton
-
25th July 2022
0
Featured
Otsuka receives positive CHMP opinion for Lupkynis (voclosporin) for the treatment of active lupus nephritis
Tess Egginton
-
22nd July 2022
0
APPROVALS
U.S. FDA approves Incyte’s Opzelura cream for vitiligo
Tess Egginton
-
20th July 2022
0
APPROVALS
EC approves PTC’s gene therapy Upstaza for AADC deficiency
Tess Egginton
-
20th July 2022
0
1
2
3
...
33
Page 2 of 33
